| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.3 |